NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
Overall NLH gets a fundamental rating of 5 out of 10. We evaluated NLH against 17 industry peers in the Health Care Providers & Services industry. NLH has an excellent financial health rating, but there are some minor concerns on its profitability. NLH has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NLH was profitable.
NLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.16%, NLH belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
With a decent Return On Equity value of 7.55%, NLH is doing good in the industry, outperforming 76.47% of the companies in the same industry.
With a decent Return On Invested Capital value of 3.43%, NLH is doing good in the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 7.55% | ||
| ROIC | 3.43% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NLH's Profit Margin of 5.35% is amongst the best of the industry. NLH outperforms 88.24% of its industry peers.
NLH's Profit Margin has declined in the last couple of years.
The Operating Margin of NLH (3.35%) is better than 70.59% of its industry peers.
NLH has a Gross Margin (38.38%) which is in line with its industry peers.
NLH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.35% | ||
| PM (TTM) | 5.35% | ||
| GM | 38.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
NLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NLH has more shares outstanding
The number of shares outstanding for NLH has been increased compared to 5 years ago.
NLH has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.48 indicates that NLH is not in any danger for bankruptcy at the moment.
NLH's Altman-Z score of 3.48 is amongst the best of the industry. NLH outperforms 88.24% of its industry peers.
The Debt to FCF ratio of NLH is 1.85, which is an excellent value as it means it would take NLH, only 1.85 years of fcf income to pay off all of its debts.
NLH has a Debt to FCF ratio of 1.85. This is amongst the best in the industry. NLH outperforms 88.24% of its industry peers.
NLH has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
NLH's Debt to Equity ratio of 0.05 is amongst the best of the industry. NLH outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.85 | ||
| Altman-Z | 3.48 |
ROIC/WACC0.48
WACC7.15%
2.3 Liquidity
NLH has a Current Ratio of 1.06. This is a normal value and indicates that NLH is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.06, NLH belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
NLH has a Quick Ratio of 1.06. This is a normal value and indicates that NLH is financially healthy and should not expect problems in meeting its short term obligations.
NLH has a better Quick ratio (1.06) than 88.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
NLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 230.33%, which is quite impressive.
NLH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.19% yearly.
NLH shows a decrease in Revenue. In the last year, the revenue decreased by -1.60%.
NLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.16% yearly.
EPS 1Y (TTM)230.33%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%192.79%
Revenue 1Y (TTM)-1.6%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%-26.16%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.25, which indicates a correct valuation of NLH.
Based on the Price/Earnings ratio, NLH is valued cheaper than 94.12% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.85. NLH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.25 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NLH is valued cheaper than 82.35% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.35 | ||
| EV/EBITDA | 11.46 |
4.3 Compensation for Growth
NLH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (4/24/2025, 7:00:00 PM)
0.245
+0.01 (+6.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.79%
Ins Owner ChangeN/A
Market Cap21.39M
Analysts84.44
Price Target0.61 (148.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.85%
Min Revenue beat(2)-9.94%
Max Revenue beat(2)-5.76%
Revenue beat(4)0
Avg Revenue beat(4)-18.48%
Min Revenue beat(4)-30.71%
Max Revenue beat(4)-5.76%
Revenue beat(8)0
Avg Revenue beat(8)-24.14%
Revenue beat(12)0
Avg Revenue beat(12)-24.52%
Revenue beat(16)0
Avg Revenue beat(16)-21.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.25 | ||
| Fwd PE | N/A | ||
| P/S | 0.6 | ||
| P/FCF | 11.35 | ||
| P/OCF | 11.14 | ||
| P/B | 0.85 | ||
| P/tB | 9.42 | ||
| EV/EBITDA | 11.46 |
EPS(TTM)0.02
EY8.16%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.81%
OCF(TTM)0.02
OCFY8.97%
SpS0.41
BVpS0.29
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 7.55% | ||
| ROCE | 4.51% | ||
| ROIC | 3.43% | ||
| ROICexc | 3.7% | ||
| ROICexgc | 57.5% | ||
| OM | 3.35% | ||
| PM (TTM) | 5.35% | ||
| GM | 38.38% | ||
| FCFM | 5.29% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score6
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.85 | ||
| Debt/EBITDA | 0.62 | ||
| Cap/Depr | 4.28% | ||
| Cap/Sales | 0.1% | ||
| Interest Coverage | 10.44 | ||
| Cash Conversion | 95.9% | ||
| Profit Quality | 98.88% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 3.48 |
F-Score6
WACC7.15%
ROIC/WACC0.48
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)230.33%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%192.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.6%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%-26.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y87.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.91%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y-35.58%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%